George C. Prendergast
Lankenau Institute for Medical Research(US)
Publications by Year
Research Areas
Tryptophan and brain disorders, Cancer Immunotherapy and Biomarkers, Cancer-related Molecular Pathways, Protein Kinase Regulation and GTPase Signaling, Immune cells in cancer
Most-Cited Works
- → Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy(2005)1,062 cited
- → Recognition by Max of its cognate DNA through a dimeric b/HLH/Z domain(1993)757 cited
- → BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression(1998)720 cited
- → Aryl hydrocarbon receptor control of a disease tolerance defence pathway(2014)665 cited
- → Methylation-Sensitive Sequence-Specific DNA Binding by the c-Myc Basic Region(1991)601 cited
- → Inhibition of Indoleamine 2,3-Dioxygenase in Dendritic Cells by Stereoisomers of 1-Methyl-Tryptophan Correlates with Antitumor Responses(2007)583 cited